Publications
335
Citations
4,126
Est. group size
~1
Recurring co-author estimate
Active years
60
Publishing since 1967
John M. Allen's research focuses on medication use patterns and disparities in cancer care, particularly examining how supportive care drugs, pain medications, and psychiatric medications are used across different racial, ethnic, and age groups of cancer patients. His work often relies on large administrative healthcare databases (such as SEER-Medicare) to study real-world treatment patterns, and also includes work on diabetes/obesity drug use, pharmacy education, and cancer health equity training programs.
Publication output has fluctuated year to year over the last decade without a clear steady increase or decrease, with recent years (2023-2025) showing a return to higher activity after a dip in 2022 and 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 7567: Predictors of antidepressant use in older adults after pancreatic cancer diagnosis: A SEER-Medicare analysis.
Cancer Research · 2026
- Abstract 7566: Use of supportive care medications is associated with pancreatic cancer tumor location at diagnosis.
Cancer Research · 2026
- Regional trends and disparities in newer <scp>GLP1</scp> receptor agonist initiation among real‐world adult patients eligible for obesity treatment
Diabetes Obesity and Metabolism · 2025
- A fair machine learning model to predict flares of systemic lupus erythematosus
JAMIA Open · 2025
- Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes
Obesity · 2025
- Training the Next Generation of Researchers to Advance Cancer Health Equity: Five Years of Experience from the Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
Journal of Cancer Education · 2025
- Chromatin remodeling protein BPTF mediates chromatin accessibility at gene promoters in planarian stem cells
BMC Genomics · 2025
- Trends and Disparities in Newer GLP1 Receptor Agonist Initiation among Real-World Adult Patients Eligible for Obesity Treatment
medRxiv · 2025
- 1079: EVALUATION OF TEACHING PHARMACY FACULTY AND STAFF TO STOP THE BLEED
Critical Care Medicine · 2025
- 1089: STUDENT SELF AND PRECEPTOR FINAL EVALUATION ALIGNMENT ON CRITICAL CARE PHARMACY PRACTICE EXPERIENCES
Critical Care Medicine · 2025
- 105: SYSTEMS-BASED APPROACH TO ICU PATIENT WORK-UP FOR PROFESSIONAL STUDENTS
Critical Care Medicine · 2025
- Author response for "Regional trends and disparities in newer <scp>GLP1</scp> receptor agonist initiation among real‐world adult patients eligible for obesity treatment"
2025
- Implementation and evaluation of a stop the bleed program at a college of pharmacy
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2025
- Abstract 3633: Exploring racial and ethnic disparities in supportive medication use for nonmetastatic colorectal cancer: a SEER-Medicare database analysis
Cancer Research · 2025
- Abstract 3632: Analysis of supportive care medication use in metastatic colorectal cancer across racial and ethnic groups using SEER-Medicare
Cancer Research · 2025
- Critical Care Medicine×11
- Cancer Epidemiology Biomarkers & Prevention×10
- JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY×9
- American Journal of Pharmaceutical Education×8
- Cancer Research×8
- Almut G. Winterstein
Medicine · The Ohio State University
- Kristin A. Casper
Medicine · The Ohio State University
- Katelyn N. Hettinger
Medicine · Purdue University West Lafayette
- Jennifer L. Rodis
Medicine · The Ohio State University
- Margie E. Snyder
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile